Bicara Therapeutics Inc. ...
13.30
0.46 (3.62%)
At close: Jan 15, 2025, 11:17 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22
Revenue n/a n/a
Cost of Revenue n/a n/a
Gross Profit n/a n/a
Operating Income -39.89M -37.66M
Interest Income 1.31M 4.00K
Pretax Income -51.98M -37.84M
Net Income -51.98M -37.84M
Selling & General & Admin 9.27M 6.34M
Research & Development 30.62M 31.31M
Other Expenses n/a n/a
Operating Expenses 39.89M 37.66M
Interest Expense n/a 112.00K
Selling & Marketing Expenses n/a n/a
Cost & Expenses 39.89M 37.66M
Income Tax 5.00K 1K
Shares Outstanding (Basic) 15.44M 15.44M
Shares Outstanding (Diluted) 15.44M 15.44M
EPS (Basic) -3.37 -2.45
EPS (Diluted) -3.37 -2.45
EBITDA -51.96M -37.72M
Depreciation & Amortization 19.00K 10.00K